The Next 10 years in the Management of Peripheral Artery Disease: Perspectives from The 'PAD 2009' Conference

L. Norgren; W. R. Hiatt; J. A. Dormandy; A. T. Hirsch; M. R. Jaff; C. Diehm; I. Baumgartner; J. J. F. Belch

doi:10.1016/j.ejvs.2010.05.005

The Next 10 years in the Management of Peripheral Artery Disease: Perspectives from The 'PAD 2009' Conference

L. Norgren, W. R. Hiatt, J. A. Dormandy, A. T. Hirsch, M. R. Jaff, C. Diehm, I. Baumgartner, J. J. F. Belch

Research output: Contribution to journal › Article › peer-review

44 Citations (Scopus)

Abstract

Objectives: To briefly inform on the conclusions from a conference on the next 10 years in the management of peripheral artery disease (PAD).

Design of the Conference: International participation, invited presentations and open discussion were based on the following issues: Why is PAD under-recognised? Health economic impact of PAD; funding of PAD research; changes of treatment options? Aspects on clinical trials and regulatory views; and the role of guidelines.

Results and Conclusions: A relative lack of knowledge about cardiovascular risk and optimal management of PAD patients exists not only among the public, but also in parts of the health-care system. Specialists are required to act for improved information.

More specific PAD research is needed for risk management and to apply the best possible evaluation of evidence for treatment strategies. Better strategies for funding are required based on, for example, public/private initiatives.

The proportion of endovascular treatments is steadily increasing, more frequently based on observational studies than on randomised controlled trials. The role of guidelines is therefore important to guide the profession in the assessment of most relevant treatment. (C) 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Original language	English
Pages (from-to)	375-380
Number of pages	6
Journal	European Journal of Vascular and Endovascular Surgery
Volume	40
Issue number	3
DOIs	https://doi.org/10.1016/j.ejvs.2010.05.005
Publication status	Published - Sept 2010

Keywords

Peripheral artery disease
Information
Research
Guidelines
RANDOMIZED CONTROLLED-TRIAL
INTERMITTENT CLAUDICATION
COST-EFFECTIVENESS
LOWER-EXTREMITY
CELL THERAPY
HEALTH-CARE
REVASCULARIZATION
EXERCISE
AWARENESS
ISCHEMIA

Access to Document

10.1016/j.ejvs.2010.05.005

Cite this

@article{172e6664043e42f3a378e1fa9874fe77,

title = "The Next 10 years in the Management of Peripheral Artery Disease: Perspectives from The 'PAD 2009' Conference",

abstract = "Objectives: To briefly inform on the conclusions from a conference on the next 10 years in the management of peripheral artery disease (PAD).Design of the Conference: International participation, invited presentations and open discussion were based on the following issues: Why is PAD under-recognised? Health economic impact of PAD; funding of PAD research; changes of treatment options? Aspects on clinical trials and regulatory views; and the role of guidelines.Results and Conclusions: A relative lack of knowledge about cardiovascular risk and optimal management of PAD patients exists not only among the public, but also in parts of the health-care system. Specialists are required to act for improved information.More specific PAD research is needed for risk management and to apply the best possible evaluation of evidence for treatment strategies. Better strategies for funding are required based on, for example, public/private initiatives.The proportion of endovascular treatments is steadily increasing, more frequently based on observational studies than on randomised controlled trials. The role of guidelines is therefore important to guide the profession in the assessment of most relevant treatment. (C) 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.",

keywords = "Peripheral artery disease, Information, Research, Guidelines, RANDOMIZED CONTROLLED-TRIAL, INTERMITTENT CLAUDICATION, COST-EFFECTIVENESS, LOWER-EXTREMITY, CELL THERAPY, HEALTH-CARE, REVASCULARIZATION, EXERCISE, AWARENESS, ISCHEMIA",

author = "L. Norgren and Hiatt, {W. R.} and Dormandy, {J. A.} and Hirsch, {A. T.} and Jaff, {M. R.} and C. Diehm and I. Baumgartner and Belch, {J. J. F.}",

year = "2010",

month = sep,

doi = "10.1016/j.ejvs.2010.05.005",

language = "English",

volume = "40",

pages = "375--380",

journal = "European Journal of Vascular and Endovascular Surgery",

issn = "1078-5884",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - The Next 10 years in the Management of Peripheral Artery Disease

T2 - Perspectives from The 'PAD 2009' Conference

AU - Norgren, L.

AU - Hiatt, W. R.

AU - Dormandy, J. A.

AU - Hirsch, A. T.

AU - Jaff, M. R.

AU - Diehm, C.

AU - Baumgartner, I.

AU - Belch, J. J. F.

PY - 2010/9

Y1 - 2010/9

N2 - Objectives: To briefly inform on the conclusions from a conference on the next 10 years in the management of peripheral artery disease (PAD).Design of the Conference: International participation, invited presentations and open discussion were based on the following issues: Why is PAD under-recognised? Health economic impact of PAD; funding of PAD research; changes of treatment options? Aspects on clinical trials and regulatory views; and the role of guidelines.Results and Conclusions: A relative lack of knowledge about cardiovascular risk and optimal management of PAD patients exists not only among the public, but also in parts of the health-care system. Specialists are required to act for improved information.More specific PAD research is needed for risk management and to apply the best possible evaluation of evidence for treatment strategies. Better strategies for funding are required based on, for example, public/private initiatives.The proportion of endovascular treatments is steadily increasing, more frequently based on observational studies than on randomised controlled trials. The role of guidelines is therefore important to guide the profession in the assessment of most relevant treatment. (C) 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

AB - Objectives: To briefly inform on the conclusions from a conference on the next 10 years in the management of peripheral artery disease (PAD).Design of the Conference: International participation, invited presentations and open discussion were based on the following issues: Why is PAD under-recognised? Health economic impact of PAD; funding of PAD research; changes of treatment options? Aspects on clinical trials and regulatory views; and the role of guidelines.Results and Conclusions: A relative lack of knowledge about cardiovascular risk and optimal management of PAD patients exists not only among the public, but also in parts of the health-care system. Specialists are required to act for improved information.More specific PAD research is needed for risk management and to apply the best possible evaluation of evidence for treatment strategies. Better strategies for funding are required based on, for example, public/private initiatives.The proportion of endovascular treatments is steadily increasing, more frequently based on observational studies than on randomised controlled trials. The role of guidelines is therefore important to guide the profession in the assessment of most relevant treatment. (C) 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

KW - Peripheral artery disease

KW - Information

KW - Research

KW - Guidelines

KW - RANDOMIZED CONTROLLED-TRIAL

KW - INTERMITTENT CLAUDICATION

KW - COST-EFFECTIVENESS

KW - LOWER-EXTREMITY

KW - CELL THERAPY

KW - HEALTH-CARE

KW - REVASCULARIZATION

KW - EXERCISE

KW - AWARENESS

KW - ISCHEMIA

U2 - 10.1016/j.ejvs.2010.05.005

DO - 10.1016/j.ejvs.2010.05.005

M3 - Article

SN - 1078-5884

VL - 40

SP - 375

EP - 380

JO - European Journal of Vascular and Endovascular Surgery

JF - European Journal of Vascular and Endovascular Surgery

IS - 3

ER -

The Next 10 years in the Management of Peripheral Artery Disease: Perspectives from The 'PAD 2009' Conference

Abstract

Keywords

Access to Document

Fingerprint

Cite this